Payment overview · 2025
General Payments
$116.19
6 reported records · 2 companies
Healthcare provider profile · identity verified
Igor Bidikov, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · HEFLIN, AL · NPI 1649247545
Verified facts
What the public records show
CMS Open Payments records show Igor Bidikov, MD received $116.19 in general payments during 2025 across 6 reported records.
Astellas Pharma US Inc accounted for 87.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Vraylar by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Myrbetriq by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $102.17 | 87.9% | 5 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $14.02 | 12.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $116.19 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cresemba Normalized: cresemba |
Drug | Astellas Pharma US Inc | $102.17 | 5 | 2025 |
Source payment records
|
|||||
| MAVYRET Normalized: mavyret |
Drug | ABBVIE INC. | $14.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1085 | 167 |
| Levothyroxine Sodium | Levothyroxine Sodium | 819 | 139 |
| Atorvastatin Calcium | Atorvastatin Calcium | 792 | 179 |
| Gabapentin | Gabapentin | 749 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 736 | 176 |
| Pantoprazole Sodium | Pantoprazole Sodium | 708 | 155 |
| Furosemide | Furosemide | 530 | 125 |
| Eliquis | Apixaban | 515 | 86 |
| Omeprazole | Omeprazole | 498 | 117 |
| Metformin Hcl | Metformin Hcl | 410 | 89 |
| Lisinopril | Lisinopril | 381 | 96 |
| Potassium Chloride | Potassium Chloride | 378 | 97 |
| Tramadol Hcl | Tramadol Hcl | 352 | 86 |
| Losartan Potassium | Losartan Potassium | 335 | 88 |
| Carvedilol | Carvedilol | 327 | 76 |
| Tamsulosin Hcl | Tamsulosin Hcl | 325 | 63 |
| Trazodone Hcl | Trazodone Hcl | 318 | 61 |
| Buspirone Hcl | Buspirone Hcl | 269 | 50 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 261 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 259 | 73 |
| Alprazolam | Alprazolam | 259 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 253 | 56 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 247 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 239 | 50 |
| Meloxicam | Meloxicam | 235 | 45 |
| Simvastatin | Simvastatin | 229 | 53 |
| Azithromycin | Azithromycin | 227 | 153 |
| Escitalopram Oxalate | Escitalopram Oxalate | 218 | 53 |
| Montelukast Sodium | Montelukast Sodium | 208 | 48 |
| Donepezil Hcl | Donepezil Hcl | 207 | 39 |
| Pregabalin | Pregabalin | 204 | 35 |
| Tizanidine Hcl | Tizanidine Hcl | 202 | 34 |
| Lorazepam | Lorazepam | 199 | 36 |
| Memantine Hcl | Memantine Hcl | 194 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 190 | 51 |
| Quetiapine Fumarate | Quetiapine Fumarate | 188 | 42 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 184 | 40 |
| Temazepam | Temazepam | 181 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 180 | 32 |
| Ondansetron Hcl | Ondansetron Hcl | 180 | 47 |
| Sertraline Hcl | Sertraline Hcl | 171 | 35 |
| Clonazepam | Clonazepam | 164 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 160 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 159 | 48 |
| Atenolol | Atenolol | 158 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 157 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 155 | 39 |
| Sucralfate | Sucralfate | 153 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 146 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 142 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 138 | 25 |
| Meclizine Hcl | Meclizine Hcl | 136 | 31 |
| Ozempic | Semaglutide | 127 | 19 |
| Prednisone | Prednisone | 124 | 30 |
| Allopurinol | Allopurinol | 121 | 25 |
| Promethazine Hcl | Promethazine Hcl | 117 | 31 |
| Diazepam | Diazepam | 115 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 115 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 108 | 13 |
| Clonidine Hcl | Clonidine Hcl | 107 | 26 |
| Trulicity | Dulaglutide | 99 | 13 |
| Glimepiride | Glimepiride | 97 | 21 |
| Risperidone | Risperidone | 97 | 11 |
| Januvia | Sitagliptin Phosphate | 96 | 13 |
| Estradiol | Estradiol | 94 | 17 |
| Levetiracetam | Levetiracetam | 92 | 16 |
| Cephalexin | Cephalexin | 89 | 67 |
| Oxybutynin Chloride | Oxybutynin Chloride | 89 | 16 |
| Mirtazapine | Mirtazapine | 88 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 87 | 19 |
| Methadone Hcl | Methadone Hcl | 87 | suppressed |
| Ondansetron Odt | Ondansetron | 87 | 32 |
| Spironolactone | Spironolactone | 85 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 84 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 82 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 80 | 60 |
| Fluconazole | Fluconazole | 80 | 48 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 80 | 22 |
| Nystatin | Nystatin | 80 | 25 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 76 | suppressed |
| Levofloxacin | Levofloxacin | 74 | 52 |
| Famotidine | Famotidine | 72 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 72 | 11 |
| Methocarbamol | Methocarbamol | 72 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 71 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 70 | 17 |
| Xarelto | Rivaroxaban | 68 | 17 |
| Alendronate Sodium | Alendronate Sodium | 67 | suppressed |
| Jardiance | Empagliflozin | 67 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 65 | 12 |
| Fenofibrate | Fenofibrate | 65 | 14 |
| Methylprednisolone | Methylprednisolone | 65 | 47 |
| Celecoxib | Celecoxib | 64 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 39 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | 17 |
| Ibuprofen | Ibuprofen | 60 | 16 |
| Aripiprazole | Aripiprazole | 59 | 12 |
| Colchicine | Colchicine | 59 | 16 |
| Divalproex Sodium | Divalproex Sodium | 58 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 58 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 54 | suppressed |
| Lactulose | Lactulose | 53 | 19 |
| Olanzapine | Olanzapine | 53 | 11 |
| Entresto | Sacubitril/Valsartan | 52 | suppressed |
| Humalog | Insulin Lispro | 51 | suppressed |
| Lidocaine | Lidocaine | 51 | 11 |
| Mupirocin | Mupirocin | 51 | 23 |
| Amoxicillin | Amoxicillin | 49 | 31 |
| Doxycycline Hyclate | Doxycycline Hyclate | 49 | 31 |
| Novolog Flexpen | Insulin Aspart | 49 | 12 |
| Venlafaxine Hcl | Venlafaxine Hcl | 49 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 48 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 48 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 47 | 15 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 46 | 15 |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 37 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 45 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Lovastatin | Lovastatin | 45 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 44 | suppressed |
| Mounjaro | Tirzepatide | 43 | 11 |
| Bupropion Xl | Bupropion Hcl | 42 | suppressed |
| Topiramate | Topiramate | 42 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 41 | 27 |
| Ventolin Hfa | Albuterol Sulfate | 40 | suppressed |
| Glipizide | Glipizide | 39 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 36 | 17 |
| Brilinta | Ticagrelor | 36 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 36 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 36 | 12 |
| Valacyclovir | Valacyclovir Hcl | 35 | 13 |
| Lamotrigine | Lamotrigine | 34 | suppressed |
| Ranolazine Er | Ranolazine | 34 | suppressed |
| Synthroid | Levothyroxine Sodium | 33 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 33 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 32 | suppressed |
| Gemtesa | Vibegron | 32 | suppressed |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 29 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 29 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 29 | 15 |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 28 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 18 |
| Primidone | Primidone | 27 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 26 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 12 |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 19 |
| Tradjenta | Linagliptin | 25 | suppressed |
| Cefdinir | Cefdinir | 24 | 22 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 24 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 23 | suppressed |
| Klor-Con M20 | Potassium Chloride | 23 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 23 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 22 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 22 | suppressed |
| Constulose | Lactulose | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Flurbiprofen | Flurbiprofen | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Nadolol | Nadolol | 20 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Rexulti | Brexpiprazole | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Glipizide Er | Glipizide | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 17 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Latanoprost | Latanoprost | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 11 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Amiloride-Hydrochlorothiazide | Amiloride/Hydrochlorothiazide | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Loxapine | Loxapine Succinate | 14 | suppressed |
| Vraylar | Cariprazine Hcl | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 12 | suppressed |
| Aripiprazole Odt | Aripiprazole | 11 | suppressed |
| Buprenorphine | Buprenorphine | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Invokana | Canagliflozin | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $116.19 · 6 records | Astellas Pharma US Inc | Cresemba, MAVYRET | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error